Brand Name | Status | Last Update |
---|---|---|
antispetic | C200263 | 2025-06-10 |
methyl salicylate | C200263 | 2025-06-04 |
methyl salicylate 10% | C200263 | 2025-06-07 |
provayblue | New Drug Application | 2025-05-28 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 1 | — | — | — | 1 |
Preleukemia | D011289 | — | — | 1 | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | 1 | 1 | — | — | — | 1 |
Drug common name | Usistapide |
INN | usistapide |
Description | Usistapide is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | microsomal triglyceride transfer protein (MTP) inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COC(=O)[C@H](c1ccccc1)N1CCC(c2ccc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)cc2)CC1 |
PDB | — |
CAS-ID | 403989-79-7 |
RxCUI | — |
ChEMBL ID | CHEMBL2103860 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 73YSY3U094 (ChemIDplus, GSRS) |